| NCI Trials reviewed by Djulbegovic et al (n = 654 comparisons) | HTA short follow up (n = 85 comparisons) | HTA short follow up with 2 comparisons for 12 comparison trial (n = 77) | HTA long term follow up (n = 85 comparisons) | HTA long term follow up with 2 comparisons for 12 comparison trial (n = 75) | |||||
---|---|---|---|---|---|---|---|---|---|---|
Classification / category | N | % | n | % | n | % | n | % | n | % |
1. Statistically significant in favour of control | 45 | 7% | 4 | 5% | 4 | 5% | 4 | 5% | 4 | 5% |
2. Statistically significant in favour of new | 176 | 27% | 16 | 19% | 15 | 20% | 13 | 15% | 13 | 17% |
3. True negative | 12 | 2% | 19 | 22% | 16 | 21% | 18 | 21% | 16 | 21% |
4. Inconclusive in favour of new | 84 | 13% | 15 | 18% | 12 | 16% | 21 | 25% | 14 | 19% |
5. Truly inconclusive | 218 | 33% | 20 | 24% | 18 | 24% | 19 | 22% | 18 | 24% |
6. Inconclusive in favour of control | 119 | 18% | 11 | 13% | 10 | 13% | 10 | 12% | 10 | 13% |
Total | 654 | 100% | 85 | 100% | 75 | 100% | 85 | 100% | 75 | 100% |